Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
This study investigated whether namilumab, a granulocyte-macrophage colony-stimulating factor inhibitor, might improve outcomes in patients with moderate or severe plaque psoriasis.
A recent head-to-head study compared risankizumab with ustekinumab for treatment of moderate-to-severe chronic plaque psoriasis. This critical assessment examines the validity of the results.
Several human polyomaviruses, including Merkel cell polyomavirus, have been isolated on the skin. Which are associated with cutaneous disease, and what do we know about their molecular mechanisms?
A novel, non-steroidal approach to treating mild-to-moderate atopic dermatis, using a TRPV1 antagonist, looks to be an effective and safe treatment modality in early trials.
Condylomata acuminata of HIV-positive men may harbour focal areas of dysplasia: relevant implications for the management of human papillomavirus-induced disease in high-risk patients.
Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ��� 50 years.
The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients.
An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult.
Preoperative prediction of histopathological outcome in basal cell carcinoma: flat surface and multiple small erosions predict superficial basal cell carcinoma in lighter skin types.
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(��) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(��) lamp.
CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal malignancies: a case series and review of the literature.
